Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
No Takers For Biogen’s Biosimilars Business?
Firm Suggests It Could Retain Biosimilars Unit Amid Lack Of ‘Acceptable’ Offers
Apr 26 2024
•
By
David Wallace
Suitors do not appear ready to smash open the piggy bank for Biogen • Source: Shutterstock
More from Deals
More from Business